EDITAS MEDICINE, INC. Increase (Decrease) in Accounts Receivable
EDITAS MEDICINE, INC. (EDIT) reported Increase (Decrease) in Accounts Receivable of -$12.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- EDITAS MEDICINE, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $133.00K, a 70.51% increase year-over-year.
- EDITAS MEDICINE, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$12.58M.
- EDITAS MEDICINE, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $7.05M, a 56.34% decline year-over-year.
- EDITAS MEDICINE, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $7.54M.
- EDITAS MEDICINE, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$1.09M, a 117.93% decline from fiscal 2024.
- EDITAS MEDICINE, INC. increase (decrease) in accounts receivable for fiscal 2024 was $6.08M, a 20.57% increase from fiscal 2023.
- EDITAS MEDICINE, INC. increase (decrease) in accounts receivable for fiscal 2023 was $5.04M, a 3.36% increase from fiscal 2022.
- EDITAS MEDICINE, INC. increase (decrease) in accounts receivable for fiscal 2022 was $4.88M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$12.45M 10-Q · filed 2026-08-05 | -$5.41M derived: sum of 3 quarters · filed 2026-08-05 | $2.14M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | -$12.58M 10-Q · filed 2026-05-05 | -$5.54M derived: sum of 2 quarters · filed 2026-05-05 | $2.00M derived: sum of 3 quarters · filed 2026-05-05 | $2.08M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | $7.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $14.59M derived: sum of 2 quarters · filed 2026-03-09 | $14.67M derived: sum of 3 quarters · filed 2026-08-05 | -$1.09M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $7.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $7.62M derived: sum of 2 quarters · filed 2026-08-05 | -$8.14M 10-Q · filed 2025-11-10 | $8.00M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$15.68M 10-Q · filed 2026-08-05 | $462.00K derived: sum of 3 quarters · filed 2026-08-05 | $344.00K derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | -$15.76M 10-Q · filed 2026-05-05 | $384.00K derived: sum of 2 quarters · filed 2026-05-05 | $266.00K derived: sum of 3 quarters · filed 2026-05-05 | $265.00K derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $16.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $16.02M derived: sum of 2 quarters · filed 2026-03-09 | $16.02M derived: sum of 3 quarters · filed 2026-03-09 | $6.08M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | -$118.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$119.00K derived: sum of 2 quarters · filed 2025-11-10 | -$10.06M 10-Q · filed 2025-11-10 | -$2.30M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$9.94M 10-Q · filed 2025-08-12 | -$2.18M derived: sum of 3 quarters · filed 2025-08-12 | -$2.04M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | -$9.94M 10-Q · filed 2025-05-12 | -$2.18M derived: sum of 2 quarters · filed 2025-05-12 | -$2.04M derived: sum of 3 quarters · filed 2025-05-12 | $3.00K derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $7.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $7.90M derived: sum of 2 quarters · filed 2025-03-05 | $9.95M derived: sum of 3 quarters · filed 2025-03-05 | $5.04M 10-K · filed 2025-03-05 | |||
| 2023-09-30 | $136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $2.18M derived: sum of 2 quarters · filed 2024-11-04 | -$2.72M 10-Q · filed 2024-11-04 | $2.30M derived: sum of 4 quarters · filed 2025-03-05 | |||
| 2023-06-30 | $2.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$2.86M 10-Q · filed 2024-08-07 | $2.17M derived: sum of 3 quarters · filed 2025-03-05 | $1.57M derived: sum of 4 quarters · filed 2025-03-05 | |||
| 2023-03-31 | -$4.90M 10-Q · filed 2024-05-08 | $122.00K derived: sum of 2 quarters · filed 2025-03-05 | -$471.00K derived: sum of 3 quarters · filed 2025-03-05 | -$1.13M derived: sum of 4 quarters · filed 2025-03-05 | |||
| 2022-12-31 | $5.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $4.43M derived: sum of 2 quarters · filed 2025-03-05 | $3.77M derived: sum of 3 quarters · filed 2025-03-05 | $4.88M 10-K · filed 2025-03-05 | |||
| 2022-09-30 | -$593.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$1.25M derived: sum of 2 quarters · filed 2023-11-03 | -$147.00K 10-Q · filed 2023-11-03 | -$131.00K derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | -$659.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $446.00K 10-Q · filed 2023-08-02 | $462.00K derived: sum of 3 quarters · filed 2024-02-28 | $382.00K derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | $1.10M 10-Q · filed 2023-05-05 | $1.12M derived: sum of 2 quarters · filed 2024-02-28 | $1.04M derived: sum of 3 quarters · filed 2024-02-28 | $700.00K derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$64.00K derived: sum of 2 quarters · filed 2024-02-28 | -$405.00K derived: sum of 3 quarters · filed 2024-02-28 | -$5.78M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | -$80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$421.00K derived: sum of 2 quarters · filed 2022-11-02 | -$5.80M 10-Q · filed 2022-11-02 | -$804.00K derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | -$341.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$5.72M 10-Q · filed 2022-08-03 | -$724.00K derived: sum of 3 quarters · filed 2023-02-22 | -$1.53M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | -$5.38M 10-Q · filed 2022-05-04 | -$383.00K derived: sum of 2 quarters · filed 2023-02-22 | -$1.19M derived: sum of 3 quarters · filed 2023-02-22 | -$1.16M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $4.18M derived: sum of 2 quarters · filed 2023-02-22 | $4.22M derived: sum of 3 quarters · filed 2023-02-22 | $5.63M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | -$810.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$777.00K derived: sum of 2 quarters · filed 2021-11-09 | $637.00K 10-Q · filed 2021-11-09 | $744.00K derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.45M 10-Q · filed 2021-08-05 | $1.55M derived: sum of 3 quarters · filed 2022-02-24 | $1.85M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | $1.41M 10-Q · filed 2021-05-06 | $1.52M derived: sum of 2 quarters · filed 2022-02-24 | $1.82M derived: sum of 3 quarters · filed 2022-02-24 | $1.83M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $406.00K derived: sum of 2 quarters · filed 2022-02-24 | $418.00K derived: sum of 3 quarters · filed 2022-02-24 | $388.00K 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $299.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $311.00K derived: sum of 2 quarters · filed 2020-11-06 | $281.00K 10-Q · filed 2020-11-06 | $268.00K derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$18.00K 10-Q · filed 2020-08-07 | -$31.00K derived: sum of 3 quarters · filed 2021-02-26 | -$350.00K derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-03-31 | -$30.00K 10-Q · filed 2020-05-08 | -$43.00K derived: sum of 2 quarters · filed 2021-02-26 | -$362.00K derived: sum of 3 quarters · filed 2021-02-26 | -$931.00K derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2018-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$332.00K derived: sum of 2 quarters · filed 2021-02-26 | -$901.00K derived: sum of 3 quarters · filed 2021-02-26 | -$649.00K 10-K · filed 2021-02-26 | |||
| 2018-09-30 | -$319.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$888.00K derived: sum of 2 quarters · filed 2019-11-12 | -$636.00K 10-Q · filed 2019-11-12 | -$652.00K derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-06-30 | -$569.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$317.00K 10-Q · filed 2019-08-07 | -$333.00K derived: sum of 3 quarters · filed 2020-02-26 | -$458.00K derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2018-03-31 | $252.00K 10-Q · filed 2019-05-08 | $236.00K derived: sum of 2 quarters · filed 2020-02-26 | $111.00K derived: sum of 3 quarters · filed 2020-02-26 | -$14.00K derived: sum of 4 quarters · filed 2020-02-26 | |||
| 2017-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$141.00K derived: sum of 2 quarters · filed 2020-02-26 | -$266.00K derived: sum of 3 quarters · filed 2020-02-26 | $591.00K 10-K · filed 2020-02-26 | |||
| 2017-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$250.00K derived: sum of 2 quarters · filed 2018-11-08 | $607.00K 10-Q · filed 2018-11-08 | -$427.00K derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $732.00K 10-Q · filed 2018-08-07 | -$302.00K derived: sum of 3 quarters · filed 2019-03-01 | -$375.00K derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2017-03-31 | $857.00K 10-Q · filed 2018-05-04 | -$177.00K derived: sum of 2 quarters · filed 2019-03-01 | -$250.00K derived: sum of 3 quarters · filed 2019-03-01 | -$163.00K derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$1.11M derived: sum of 2 quarters · filed 2019-03-01 | -$1.02M derived: sum of 3 quarters · filed 2019-03-01 | -$931.00K 10-K · filed 2019-03-01 | |||
| 2016-09-30 | -$73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $14.00K derived: sum of 2 quarters · filed 2017-11-08 | $103.00K 10-Q · filed 2017-11-08 | -$103.00K 10-Q · filed 2016-11-09 | $2.16M derived: sum of 4 quarters · filed 2018-03-08 | ||
| 2016-06-30 | $87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $176.00K 10-Q · filed 2017-08-09 | -$176.00K 10-Q · filed 2016-08-10 | $2.23M derived: sum of 3 quarters · filed 2018-03-08 | $1.40M derived: sum of 4 quarters · filed 2018-03-08 | ||
| 2016-03-31 | $89.00K 10-Q · filed 2017-05-15 | -$89.00K 10-Q · filed 2016-05-13 | $2.15M derived: sum of 2 quarters · filed 2018-03-08 | $1.31M derived: sum of 3 quarters · filed 2018-03-08 | |||
| 2015-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $1.22M derived: sum of 2 quarters · filed 2018-03-08 | $1.02M 10-K · filed 2018-03-08 | ||||
| 2015-09-30 | -$840.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$1.04M 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | -$200.00K 10-Q · filed 2016-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |